NCT03025386

Brief Summary

A cochlear implant is a device for the rehabilitation of severe to profound hearing loss. Despite the standardization of surgical procedures and rehabilitation, speech discrimination performance varied significantly in cochlear implant users and could be improved by early individualized cares. However, there is no objective method yet to evaluate phonemes discrimination, especially in infants, which account for more than half of the indications for implantation. In electroencephalography (EEG), it is possible to highlight the discrimination of auditory stimuli studying the wave of MisMatch Negativity (MMN). In this work, this study propose to use the MMN as an objective vocal audiometry method to evaluate the ability to discriminate phonemes, the smallest units of oral language, in adult cochlear implant users.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 19, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

May 18, 2017

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2022

Completed
Last Updated

September 30, 2025

Status Verified

January 1, 2023

Enrollment Period

5 years

First QC Date

January 16, 2017

Last Update Submit

September 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between MMN amplitude and logatoms discrimination score in the discrimination capacity

    The discrimination capacity (positive/ negative) defined by an MMN amplitude above a threshold will be estimated using a ROC curve based on the logatoms discrimination scores The discrimination capacity defined by logatoms test will be positive if the discrimination score is higher or equal to 80%.

    30 days

Secondary Outcomes (1)

  • Correlation between MMN amplitude and the Phonetically Balanced Kindergarten score and Vocoder test

    within the first 30 days after the first visit

Study Arms (1)

Adult cochlear implant users

OTHER

Evaluation of a concordance between the mismatch negativity amplitude mesured by electroencephalography and the capacity of logatoms discrimination by using a logatoms test

Other: logatoms testOther: Electroencephalography

Interventions

A forced choice test will evaluate the discrimination of the most confusing logatoms in the cochlear implant users, and representative of the French language.

Adult cochlear implant users

Mesure of the mismatch negativity wave

Adult cochlear implant users

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged from 18 to 75
  • Severe to profound deafness
  • Cochlear implant user for over a year
  • Affiliation or beneficiary of the social insurance

You may not qualify if:

  • Phonetically balanced kindergarten score less than 25%
  • No steady setting
  • Contralateral hearing aid
  • Electroacoustic stimulation device or bilateral cochlear implant user
  • Inactive electrodes \> 3
  • Cochlear Implant wore less than 7 hours per day
  • Disorders of memory, attention or executive functions
  • Associated disorders with deafness
  • No informed consent
  • Patient participating in other biomedical research
  • Patient who has undergone cochlear reimplantation or brain surgery
  • Withdrawal of consents
  • Patient lost to follow-up
  • Death

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Montpellier

Montpellier, 34000, France

Location

Study Officials

  • Frédéric VENAIL, PH

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2017

First Posted

January 19, 2017

Study Start

May 18, 2017

Primary Completion

June 2, 2022

Study Completion

June 2, 2022

Last Updated

September 30, 2025

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations